PD-L1 Expression is Related to Tumor Staging in NSCLC

被引：0
|
作者：
Wang, Hangjun
Agulnik, Jason [1 ,2 ]
Kasymjanova, Goulnar [3 ]
Wang, Anna Y. [1 ,2 ]
Cohen, Victor [1 ,2 ]
Small, David [1 ,2 ]
Pepe, Carmela [1 ,2 ]
Sakr, Lama [1 ,2 ]
Fiset, Pierre O. [4 ]
Auger, Manon
Camilleri-Broet, Sophie [2 ,4 ]
Alameldin, Mona [2 ,4 ]
Chong, George [2 ,4 ]
van Kempen, Leon [2 ,4 ]
Spatz, Alan [2 ,4 ]
机构：
[1] Jewish Gen Hosp, Montreal, PQ, Canada
[2] McGill Univ, Montreal, PQ, Canada
[3] JGH, Montreal, PQ, Canada
[4] McGill Univ, Hlth Ctr, Glen Site, Montreal, PQ, Canada
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
2114
引用
收藏
页码：755 / 755
页数：1
相关论文
共 50 条
  • [1] PD-L1 Expression is Related to Tumor Staging in NSCLC
    Wang, Hangjun
    Agulnik, Jason
    Kasymjanova, Goulnar
    Wang, Anna Y.
    Cohen, Victor
    Small, David
    Pepe, Carmela
    Sakr, Lama
    Fiset, Pierre O.
    Auger, Manon
    Camilleri-Broet, Sophie
    Alameldin, Mona
    Chong, George
    van Kempen, Leon
    Spatz, Alan
    [J]. MODERN PATHOLOGY, 2018, 31 : 755 - 755
  • [2] PD-L1 expression in NSCLC
    Janzic, U.
    Kern, I.
    Janzic, A.
    Cavka, L.
    Cufer, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S58 - S59
  • [3] Prior Therapy and Increased Expression of PD-L1 in NSCLC Tumor Samples
    Boothman, A.
    Scott, M.
    Ratcliffe, M.
    Whiteley, J.
    Dennis, P.
    Wadsworth, C.
    Sharpe, A.
    Rizvi, N.
    Garassino, M.
    Walker, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S422 - S422
  • [4] Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
    Janning, Melanie
    Kobus, Franca
    Babayan, Anna
    Wikman, Harriet
    Velthaus, Janna-Lisa
    Bergmann, Sonja
    Schatz, Stefanie
    Falk, Markus
    Berger, Lars-Arne
    Boettcher, Lisa-Marie
    Paesler, Sarina
    Gorges, Tobias M.
    O'Flaherty, Linda
    Hille, Claudia
    Joosse, Simon A.
    Simon, Ronald
    Tiemann, Markus
    Bokemeyer, Carsten
    Reck, Martin
    Riethdorf, Sabine
    Pantel, Klaus
    Loges, Sonja
    [J]. CANCERS, 2019, 11 (06):
  • [5] Extrinsic Upregulation of PD-L1 Induced by Pembrolizumab Combination Therapy in Patients with NSCLC with Low Tumor PD-L1 Expression
    Kunimasa, Kei
    Nakamura, Harumi
    Nishino, Kazumi
    Nakatsuka, Shin-ichi
    Kumagai, Toru
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : E231 - E233
  • [6] PD-L1 expression in NSCLC and biopsy size
    Kern, I.
    Kovacevic, M.
    Janzic, U.
    Cufer, T.
    [J]. VIRCHOWS ARCHIV, 2016, 469 : S127 - S127
  • [7] Biological and clinical relevance of PD-L1 expression in tumor and inflammatory cells in NSCLC
    Bais, Carlos
    Morehouse, Chris
    Higgs, Brandon W.
    Marlon, Rebelatto
    Steele, Keith
    Jin, Xiaoping
    Shi, Li
    Korolevich, Susana
    Gupta, Ashok
    Ranade, Koustubh
    [J]. CANCER RESEARCH, 2017, 77
  • [8] Characterization of PD-L1 Expression Related to Unique Genes in NSCLC Tissue Samples
    Garon, Edward B.
    Mckenna, Robert
    Dering, Judy
    Wolf, Brian
    Pitts, Sharon
    Kamranpour, Naeimeh
    Chen, Hsiaowang
    Lisberg, Aaron
    Cameron, Robert B.
    Lee, Jay M.
    Dubinett, Steven M.
    Slamon, Dennis J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S198 - S198
  • [9] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
    Lin, Heng
    Wei, Shuang
    Vatan, Linda
    Kryczek, Ilona
    Zou, Weiping
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [10] PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC
    Kojima, Kensuke
    Sakamoto, Tetsuki
    Kasai, Takahiko
    Kagawa, Tomoko
    Yoon, Hyungeun
    Atagi, Shinji
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
12345